The Impacts of Covid-19 Infection and Evidences on Caring during Pregnancy, Childbirth, and Postpartum Period
บทคัดย่อ
The novel Coronavirus disease 2019 or COVID-19 is an emerging infectious disease, which is very contagious. The virus has quickly spread around the world, resulting in substantial deaths worldwide. Pregnant women with COVID-19 infection are at a higher risk of increasing complications or adverse outcomes on both pregnant women themselves and their fetuses compared to general people. Those complications and undesirable outcomes can be very severe, which probably cause maternal and fetal deaths especially in pregnant women with any underlying disease. Also, there are controversial concerns regarding current practice for infected pregnant women, pregnant women during childbirth and postpartum mothers and newborns. This article describes the results of a literature review and evidence from both national and international publications according to the impacts of COVID-19 infection during pregnancy as well as caring practices for infected pregnant women, pregnant women during childbirth and postpartum mothers and newborns. The included evidence in this article can be used for caring and monitoring of mothers and babies in order to keep them from possible complications and undesirable outcomes.
เอกสารอ้างอิง
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany. N Eng J Med 2020; 382(10): 970-71.
World Health Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]. [Cited 25
November 2021]. Available from: https://covid19.who.int/.
กรมควบคุมโรค. รายงานสถานการณ์ โควิด-19 ในประเทศไทยโรคติดเชื้อไวรัสโคโรนา 2019
(COVID-19) [อินเทอร์เน็ต]. [เข้าถึงเมื่อ 25 พฤศจิกายน 2564]. เข้าถึงได้จาก
https://ddc.moph.go.th/viralpneumonia/.
Center for Disease Control and Prevention. COVID-19: Pregnant and recently pregnant people [Internet]. [Cited 25 November 2021]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnant-people.html #anchor_1614967129618
กรมอนามัย กระทรวงสาธารณสุข. รายงานสถานการณ์ โควิด-19 ในประเทศไทย [อินเทอร์เน็ต].
[เข้าถึงเมื่อ 25 พฤศจิกายน 2564]. เข้าถึงได้จาก http://covid19.anamai.moph.go.th/th/.
Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A. et al. Maternal and neonatal morbidity and mortality mmong pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr 2021;175(8):817-26.
Center for Disease Control and Prevention. Symptoms of COVID-19 [Internet]. Updated Feb. 22, 2021. [Cited 17 April 2564]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223):497-506.
Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population-based cohort study. BMJ 2020; 369:m2107. doi:10.1136/bmj.m2107.
Yang X, Wang M, Zhu Z, Liu H. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review. J Matern Fetal Neonatal Med 2020; 33(15), 1-4. doi:10.1080/14767058.2020.1759541.
Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection in pregnancy. [Cited 22 June 2021]. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/ 2021-08-25-coronavirus-covid-19-infection-in-pregnancy-v14.pdf
Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy: emerging infectious diseases 2006; 12(11): 1638-43.
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020;370:m3320. doi:10.1136/bmj.m3320.
Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States. MMWR Morb Mortal Wkly Rep 2020; 69(44): 1641-47.
Galang RR, Newton SM, Woodworth KR, Griffin I, Oduyebo T, Sancken CL, et al. Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection – surveillance for emerging threats to mothers and babies network, 20 state, local, and territorial health departments, March 29, 2020 -January 8, 2021. Clin Infect Dis 2021;73(Suppl 1):S17-23.
Elsaddig M, Khalil A. Effects of the COVID pandemic on pregnancy outcomes. Best Pract Res Clin Obstet Gynaecol 2021; 73: 125-36.
Vousden N, Bunch K, Morris E, Simpson N, Gale C, O’Brien P, et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS). PloS one 2021; 16(5): e0251123.
Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy -SET-NET, 16 Jurisdictions, March 29–October 14, 2020. MMWR Morb Mortal Wkly Rep 2020; 69(44): 1635-40.
Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020; 11: 3572. doi: 10.1038/s41467-020-17436-6.
Zhang P, Salafia C, Heyman T, Salafia C, Lederman S, Dygulska B. Detection of severe acute respiratory syndrome coronavirus 2 in placentas with pathology and vertical transmission. Am. J. Obstet. Gynecol MFM 2020, 2(4):100197. doi: 10.1016/j.ajogmf.2020.100197.
Taglauer E, Benarroch Y, Rop K, Barnett E, Sabharwal V, Yarrington C, et al. Consistent localization of SARS- CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta 2020; 100: 69-74.
Wong YP, Khong TY, Tan GC. The effects of COVID-19 on placenta and pregnancy: what do we know so far? Diagnostics 2021; 11(1): 94. doi: 10.3390/diagnostics11010094.
Menter T, Mertz KD, Jiang S, Chen H, Monod C, Tzankov A, et al. Placental pathology findings during and after SARS-CoV-2 infection: features of villitis and malperfusion. Pathobiology 2020; 88: 69-77.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507-13.
Ferraiolo A, Barra F, Kratochwila C, Paudice M, Vellone VG, Godano E, et al. Report of positive placental swabs for SARS-CoV-2 in an asymptomatic pregnant woman with COVID-19. Medicina 2020; 56(6): 306. doi: 10.3390/medicina56060306.
Sisman J, Jaleel MA, Moreno W, Rajaram V, Collins RR, Savani RC, et al. Intrauterine transmission of SARS-CoV-2 infection in a preterm infant. Pediatr Infect Dis J 2020; 39(9):e265-67.
Dong L, Tian J, He S, Zhu C, Wang J, Liu C, et al. Possible Vertical Transmission of SARS-CoV-2 from an Infected mother to her newborn. JAMA 2020;323(18): 1846-48.
Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224(1):35-53 e33.
Akhtar H, Patel C, Abuelgasim E, Harky A. COVID-19 (SARS-CoV-2) Infection in pregnancy: a systematic review. Gynecol Obstet Invest 2020; 85: 295-306.
AbdelMassih A, Fouda R, Essam R, Negm A, Khalil D, Habib D, et al. COVID-19 during pregnancy
should we really worry from vertical transmission or rather from fetal hypoxia and placental insufficiency? A systematic review. Egypt Pediatric Association Gaz 2021; 69(1): 12. doi: 10.1186/s43054-021-00056-0.
Vora KS, Sundararajan A, Saiyed S, Dhama K, Natesan S. Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development. Hum Vaccin Immunother 2020; 16(12):2932-37.
Center for Disease Control and Prevention. V-safe COVID-19 vaccine pregnancy registry [Internet]. [Cited 25 October 2021]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafepregnancyregistry.html
Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mRNA COVID-19 vaccine safety in pregnant persons. N Engl J Med 2021;384(24):2273-82.
Public Health England. COVID-19: the green book, chapter 14a. Coronavirus (COVID-19)
vaccination information for public health professionals [Internet]. Updated 30 July 2021. [Cited 25 October 2021]. Available from: https://assets.publishing.service.gov.uk/government/uploads/ system/uploads/ attachment_data/file/1018444/Greenbook_chapter_14a_16Sept21.pdf
ราชวิทยาลัยสูตินรีแพทย์แห่งประเทศไทย. ประกาศราชวิทยาลัยสูตินรีแพทย์แห่งประเทศไทยเรื่องการ
ฉีดวัคซีนป้องกันโรคโควิด-19 ในสตรีตั้งครรภ์หรือสตรีให้นมบุตร [อินเทอร์เน็ต]. 2564. [เข้าถึงเมื่อ 22 มิถุนายน 2564]. เข้าถึงได้จาก: http://www.rtcog.or.th/home/ประกาศ-เรื่อง-การฉีดวัคซีน/4976/.
Cai J, Tang M, GaoY , Zhang H, Yang Y, Zhang D, et al. Cesarean section or vaginal delivery to prevent possible vertical transmission from a pregnant mother confirmed with COVID-19 to a neonate: a systematic review. Front Med (Lausanne) 2021; 8: 634949. doi10.3389/fmed 2021.
Ferrazzi E, Frigerio L, Savasi V, Vergani P, Prefumo F, Barresi S, et al. Vaginal delivery in
SARS‐CoV‐2‐infected pregnant women in Northern Italy: a retrospective analysis. BJOG 2020; 127(9): 1116-21.
Liao J, He X, Gong Q, Yang L, Zhou C, Li J. Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID‐19 pandemic. Int J Gynaecol Obstet 2020; 150(1): 53-57.
Martinez-Perez O, Vouga M, Melguizo SC, Forcen Acebal LF, Panchaud A, Munoz-Chapuli M, et al. Association between mode of delivery among pregnant women with COVID-19 and maternal and neonatal outcomes in Spain. JAMA 2020; 324(3):296- 99.
Jimenez IM, Lopez RS, Rosas EG, Torre IR, Garcıa JM, Conty ML, et al. Umbilical cord clamping and skin-to-skin contact in deliveries from women positive for SARS-CoV- 2: a prospective observational study. BJOG 2021; 128(5):908-15.
World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected [Internet]. [Cited 22 June 2021]. Available from: https://apps.who.int/iris/bitstream/handle/10665/331446/WHO-2019-nCoV-clinical-2020.4-eng.pdf?sequence=1&isAllowed=y
Centers for Disease Control and Prevention. Care for breastfeeding women: interim guidance on breastfeeding and breast milk feeds in the context of COVID-19 [Internet]. 2020. [Cited 15 June 2021]. Available from: https://stacks.cdc.gov/view/cdc/89077
Tam PCK, Ly KM, Kernich ML, Spurrier N, Lawrence D, Gordon DL, et al. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19). Clin Infect Dis 2020; 72(1):128-30.
Centeno-Tablante E, Medina-Rivera M, Finkelstein JL, Rayco-Solon P, Garcia-Casal MN, Rogers L, et al. Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review. Ann N Y Acad Sci 2021;1484(1): 32-54.
Solis-García G, Gutiérrez-Vélez A, Chamorro IP, Zamora-Flores E, Vigil-Vázquez S, Rodríguez-Corrales E, et al. Epidemiology, management and risk of SARS-CoV-2 transmission in a cohort of newborns born to mothers diagnosed with COVID-19 infection. Anales de Pediatr 2021; 94(3):173-78.
ดาวน์โหลด
เผยแพร่แล้ว
เวอร์ชัน
- 2022-01-05 (2)
- 2021-12-31 (1)
ฉบับ
บท
การอนุญาต
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพิ์เป็นลิขสิทธิ์ของวารสารโรงพยาบาลชลบุรี